EUVIMEDEUVIMED entdecken
Leitlinie

NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026

Daniel E Spratt, Sandy Srinivas, Nabil Adra, Bilawal Ahmed, Yi An, Rhonda Bitting, Brian Chapin, Heather H Cheng, Steve Y Cho, Anthony Victor D'Amico, Neil Desai, Tanya Dorff und 29 weitere

Journal of the National Comprehensive Cancer Network · 2026-05 · 24 (5) · 140-149

DOI: 10.6004/jnccn.2026.0023 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-05. Verfasst von Daniel E Spratt und 40 weiteren Autor:innen. Beteiligte Einrichtung: 1Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel’s discussions on select 2026 updates to the guidelines regarding nonmetastatic disease: the elimination of the very-low-risk group, updates to the Principles of Active Surveillance, and caution in the use of focal therapy in newly diagnosed patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsHumansMaleNeoplasm StagingRisk Assessment

Autor:innen und Institutionen

  • 1Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • 2Stanford Cancer Institute.
  • 3Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
  • 4The University of Tennessee Health Science Center.
  • 5Yale Cancer Center/Smilow Cancer Hospital.
  • 6Duke Cancer Institute.

Zitieren

APA

Spratt, D. E., Srinivas, S., Adra, N., Ahmed, B., An, Y., Bitting, R., Chapin, B., Cheng, H. H., Cho, S. Y., D'Amico, A. V., Desai, N., Dorff, T., Eastham, J. A., Farrington, T. A., Gao, X., Gupta, S., Ippolito, J. E., Karnes, R. J., Kishan, A. U., …, & Freedman-Cass, D. (2026). NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026. Journal of the National Comprehensive Cancer Network, 24(5), 140-149. https://doi.org/10.6004/jnccn.2026.0023

Vancouver

Spratt DE, Srinivas S, Adra N, Ahmed B, An Y, Bitting R, et al. NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026. Journal of the National Comprehensive Cancer Network. 2026;24(5):140-149. doi:10.6004/jnccn.2026.0023

BibTeX
@article{Spratt2026,
  author = {Spratt, Daniel E and Srinivas, Sandy and Adra, Nabil and Ahmed, Bilawal and An, Yi and Bitting, Rhonda and Chapin, Brian and Cheng, Heather H and Cho, Steve Y and D'Amico, Anthony Victor and Desai, Neil and Dorff, Tanya and Eastham, James A and Farrington, Thomas A and Gao, Xin and Gupta, Shilpa and Ippolito, Joseph E and Karnes, R Jeffrey and Kishan, Amar U and Kuettel, Michael R and Lang, Joshua M and Lee, Daniel and Lotan, Tamara and McDonald, Andrew and Morgan, Todd M and Pessoa, Rodrigo and Rais-Bahrami, Soroush and Roach, Mack and Robin, Tyler and Rosenfeld, Stan and Scarpato, Kristen R and Seibert, Tyler and Shabsigh, Ahmad and Szmulewitz, Russell and Teply, Benjamin A and Tward, Jonathan and Valicenti, Richard and VanderWeele, David and Wong, Jessica Karen and Kovach, Emily and Freedman-Cass, Deborah},
  title = {NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  volume = {24},
  number = {5},
  pages = {140--149},
  doi = {10.6004/jnccn.2026.0023}
}
Kostenlos starten →